As of close of business last night, Imago BioSciences Inc.’s stock clocked out at $35.59, up 104.54% from its previous closing price of $17.40. In other words, the price has increased by $+18.19 from its previous closing price. On the day, 20441521 shares were traded. IMGO stock price reached its highest trading level at $35.75 during the session, while it also had its lowest trading level at $35.44.
To gain a deeper understanding of IMGO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.20 and its Current Ratio is at 13.20. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on October 28, 2022, initiated with a Outperform rating and assigned the stock a target price of $25.
On February 14, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $37.
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 02 when Eichorn Laura G. sold 553 shares for $18.00 per share. The transaction valued at 9,954 led to the insider holds 207,737 shares of the business.
Tapper Amy E. sold 750 shares of IMGO for $13,425 on Nov 02. The insider now owns 119,047 shares after completing the transaction at $17.90 per share. On Aug 22, another insider, Eichorn Laura G., who serves as the Chief Financial Officer of the company, sold 447 shares for $18.00 each. As a result, the insider received 8,046 and left with 207,737 shares of the company.
Stock Price History:
Over the past 52 weeks, IMGO has reached a high of $27.04, while it has fallen to a 52-week low of $11.56. The 50-Day Moving Average of the stock is 16.13, while the 200-Day Moving Average is calculated to be 17.18.
It appears that IMGO traded 123.13K shares on average per day over the past three months and 191.73k shares per day over the past ten days. A total of 33.77M shares are outstanding, with a floating share count of 31.70M. Insiders hold about 1.50% of the company’s shares, while institutions hold 95.70% stake in the company. Shares short for IMGO as of Oct 13, 2022 were 3.54M with a Short Ratio of 3.54M, compared to 3.44M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 10.48% and a Short% of Float of 14.10%.
As of right now, 5 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.45 for the current quarter, with a high estimate of -$0.42 and a low estimate of -$0.49, while EPS last year was -$0.44. The consensus estimate for the next quarter is -$0.5, with high estimates of -$0.44 and low estimates of -$0.53.
Analysts are recommending an EPS of between -$1.76 and -$1.91 for the fiscal current year, implying an average EPS of -$1.84. EPS for the following year is -$2.44, with 5 analysts recommending between -$1.9 and -$3.06.